BOALF yields 6.61% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, BOALF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BOALF + JNJ for your $10,000?
Boral Limited manufactures and supplies building and construction materials in Australia. The company operates through Construction Materials and Property segments. It provides asphalt products, such as INNOVA system, UltraPatch, Durapave, and GATT Surfacing; bulk cement, slag, lime, dry mixes, specialty sands and gravels, and related products; and aggregates, crushed rock and roadbase, sand, recycled, specialty rocks, other quarry materials, and fill material. The company also offers transport and pacing services; and supplies concrete to industrial, commercial, and residential building projects. In addition, it is involved in property development and divestment activities. The company was incorporated in 1946 and is headquartered in North Ryde, Australia. Boral Limited is a subsidiary of Network Investment Holdings Pty Limited.
Full BOALF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.